2021 American Transplant Congress

June 4-9, 2021

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

View by Title View Sessions View Topics

View by Date

Monday, June 7, 2021

7:30pm-7:40pm: T-Cell Exhaustion in EBV DNAemic Solid Organ Transplant Recipients

S. Kothari, T. Ku, D. Kumar, A. Humar, V. H. Ferreira

Infectious Disease 1 • Virtual

7:40pm-7:50pm: Covid-19 Incidence Was Initially Associated with Posttransplant Kidney Graft Failure

A. Wey¹, J. Miller¹, D. Musgrove¹, N. Salkowski¹, M. Tabaka¹, R. Hirose², A. Massie³, D. Segev³, A. Israni¹, J. Snyder¹, B. Kasiske¹

Quality Assurance Process Improvement & Regulatory Issues • Virtual

7:40pm-7:50pm: Development of De Novo Antibody in Renal Transplant Recipients with BK Viremia Managed with Immunosuppression Reduction

R. Hod Dvorai¹, R. Lee², P. Muluhngwi², M. Raijmakers³, A. Shetty², A. Tambur², M. Ison²

Infectious Disease 1 • Virtual

7:40pm-7:50pm: Endothelial-to-Myofibroblast Transition (en-mt) and Low Expression of Capillary Vegf Enhance the Development of Interstitial Fibrosis and Glomerulosclerosis Induced by Microvascular Destruction in Antibody-Mediated Rejection (abmr) Patients

B. Ozdemir¹, E. Akcay¹, A. Ok Atilgan¹, M. Haberal²

Kidney Alloimmune Responses • Virtual

7:40pm-7:50pm: Risk Classification Models for Kidney Graft Failure

M. G. Naik¹, K. Budde¹, D. Telmo Neves²

Organ Inclusive • Virtual

7:40pm-7:50pm: Single-Cell RNA-seq Identifies Intra-Graft Population Heterogeneity in Acute Heart Allograft Rejection in the Mouse

C. Wu¹, Y. Tang¹, X. Shi¹, X. He¹, X. Li²

Basic 1 • Virtual

7:50pm-8:00pm: Adenovirus-Specific T Cells for Steering of Immunosuppression After Pediatric Kidney Transplantation in the Randomized Controlled Ivist Trial

T. Ahlenstiel-Grunow¹, X. Liu², R. Schild³, J. Oh³, C. Taylan⁴, L. T. Weber⁴, H. Staude⁵, M. Verboom⁶, C. Schröder⁷, R. Sabau⁷, A. Großhennig², L. Pape¹

Kidney Alloimmune Responses • Virtual

7:50pm-8:00pm: Associations of Mammalian Target of Rapamycin Inhibitors with Post-Transplant Malignancies and All-Cause Mortality: Cause-Specific Competing Risks and Composite Outcomes Analyses

A. H. Santos¹, E. Bueno¹, M. A. Leghrouz¹, W. Xuerong²

Organ Inclusive • Virtual

7:50pm-8:00pm: Centre Variation in Emergency Hospital Readmissions Following Renal Transplantation in England

J. Peracha¹, D. Pitcher¹, R. Steenkamp¹, J. Medcalf², G. Lipkin³, D. Nitsch⁴, W. McKane⁵

Quality Assurance Process Improvement & Regulatory Issues • Virtual

7:50pm-8:00pm: De Novo Hepatitis B Infection Following Liver Transplant with Hepatitis B Core Antibody Positive Graft

L. J. Myhre¹, K. D. Watt², B. A. Aqel³

Infectious Disease 1 • Virtual